PHASE-II EVALUATION OF ADRIAMYCIN (NSC-123127) AS TREATMENT FOR DISSEMINATED BREAST-CANCER

被引:0
|
作者
AHMANN, DL [1 ]
BISEL, HF [1 ]
HAHN, RG [1 ]
机构
[1] MAYO CLIN,DIV MED ONCOL,ROCHESTER,MN 55901
来源
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1974年 / 15卷 / MAR期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:100 / 100
页数:1
相关论文
共 50 条
  • [21] ADRIAMYCIN (NSC-123127) PLUS 5-FLUOROURACIL (NSC-19893) - PHASE-1 STUDY
    TRANUM, BL
    STEPHENS, RL
    LEHANE, DE
    HOOGSTRATEN, B
    LANE, M
    HAUT, A
    CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (06): : 1163 - 1165
  • [22] ADRIAMYCIN (NSC-123127) VERSUS 5-FLUOROURACIL (NSC-19893) AND CYCLOPHOSPHAMIDE (NSC-26271) IN TREATMENT OF METASTATIC PROSTATE CANCER
    EAGAN, RT
    HAHN, RG
    MYERS, RP
    CANCER TREATMENT REPORTS, 1976, 60 (01): : 115 - 117
  • [23] COMBINATION CHEMOTHERAPY WITH ADRIAMYCIN (NSC-123127) AND CYCLOPHOSPHAMIDE (NSC-26271) FOR SOLID TUMORS - PHASE-2 TRIAL
    LLOYD, RE
    JONES, SE
    SALMON, SE
    DURIE, BGM
    MCMAHON, LJ
    CANCER TREATMENT REPORTS, 1976, 60 (01): : 77 - 83
  • [24] APPLICATION OF ADRIAMYCIN IN TREATMENT OF DISSEMINATED BREAST-CANCER
    DYMARSKY, LY
    SANCHAKOVA, AV
    ALEXANDROVA, GI
    TRISHKINA, YA
    VOPROSY ONKOLOGII, 1984, 30 (06) : 67 - 73
  • [25] COMPARISON OF DAUNORUBICIN (NSC-83142) WITH ADRIAMYCIN (NSC-123127) IN TREATMENT OF LATE-STAGE CHILDHOOD SOLID TUMORS
    EVANS, AE
    BAEHNER, RL
    CHARD, RL
    LEIKIN, SL
    PANG, EM
    PIERCE, M
    CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (05): : 671 - 676
  • [26] PHASE-II EVALUATION OF BISANTRENE IN METASTATIC BREAST-CANCER
    CAVALLI, F
    GERARD, B
    HUININK, WT
    CLAVEL, M
    ROZENCWEIG, M
    CANCER TREATMENT REPORTS, 1985, 69 (03): : 337 - 338
  • [27] ADRIAMYCIN (NSC-123127) IN TREATMENT OF ALKYLATOR-RESISTANT MULTIPLE-MYELOMA - PILOT-STUDY
    ALBERTS, DS
    SALMON, SE
    CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (02): : 345 - 350
  • [28] RANDOMIZED PHASE-II TRIAL OF RUBIDAZONE AND ADRIAMYCIN IN WOMEN WITH ADVANCED BREAST-CANCER
    INGLE, JN
    AHMANN, DL
    OFALLON, JR
    BISEL, HF
    RUBIN, J
    KVOLS, LK
    GIULIANI, ER
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 1701 - 1705
  • [29] PHASE 2 TRIAL OF 5-FLUOROURACIL (NSC-19893), ADRIAMYCIN (NSC-123127), AND METHOTREXATE (NSC-740) IN LUNG ADENOCARCINOMA
    LOWITZ, BB
    CANCER TREATMENT REPORTS, 1976, 60 (05): : 623 - 624
  • [30] PHASE-II EVALUATION OF INTERFERON ADDED TO TAMOXIFEN IN THE TREATMENT OF METASTATIC BREAST-CANCER
    MACHELEDT, JE
    BUZDAR, AU
    HORTOBAGYI, GN
    FRYE, DK
    GUTTERMAN, JU
    HOLMES, FA
    BREAST CANCER RESEARCH AND TREATMENT, 1991, 18 (03) : 165 - 170